Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
Vaccines|February 26, 2022
Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 VaccinationAngelos Hatzakis, Andreas Karabinis, Sotirios Roussos, et al.
RMD Open|November 3, 2021
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, et al.
Life (Basel, Switzerland)|August 23, 2020
Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the PandemicMarius Surleac, Leontina Banica, Corina Casangiu, et al.
Scientific Reports|September 20, 2016
A contaminant-free assessment of Endogenous Retroviral RNA in human plasmaTimokratis Karamitros, Dimitrios Paraskevis, Angelos Hatzakis, et al.
AIDS (London, England)|November 9, 2016
Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjectsTetyana I Vasylyeva, Samuel R Friedman, Jose Lourenco, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
Human Endogenous Retrovirus-K HML-2 integration within RASGRF2 is associated with intravenous drug abuse and modulates transcription in a cell-line modelTimokratis Karamitros, Tara Hurst, Emanuele Marchi, et al.
Current HIV Research|November 23, 2017
Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four YearsEvangelia Kostaki, Gkikas Magiorkinis, Mina Psichogiou, et al.
Rheumatology (Oxford, England)|August 3, 2022
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort studyVasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, et al.
Viruses|August 6, 2020
Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIsAlina Kirichenko, Ilya Lapovok, Pavel Baryshev, et al.
Pageof 20